Abstract
Eosinophils are a subset of differentiated granulocytes which circulate in peripheral blood and home in several body tissues. Along with their traditional relevance in helminth immunity and allergy, eosinophils have been progressively attributed important roles in a number of homeostatic and pathologic situations. This review aims at summarizing available evidence about eosinophils functions in homeostasis, infections, allergic and autoimmune disorders, and solid and hematological cancers.
Their structural and biological features have been described, along with their physiological behavior. This includes their chemokines, cytokines, granular contents, and extracellular traps. Besides, pathogenic- and eosinophilic-mediated disorders have also been addressed, with the aim of highlighting their role in Th2-driven inflammation. In allergy, eosinophils are implicated in the pathogenesis of atopic dermatitis, allergic rhinitis, and asthma. They are also fundamentally involved in autoimmune disorders such as eosinophilic esophagitis, eosinophilic gastroenteritis, acute and chronic eosinophilic pneumonia, and eosinophilic granulomatosis with polyangiitis. In infections, eosinophils are involved in protection not only from parasites but also from fungi, viruses, and bacteria. In solid cancers, local eosinophilic infiltration is variably associated with an improved or worsened prognosis, depending on the histotype. In hematologic neoplasms, eosinophilia can be the consequence of a dysregulated cytokine production or the result of mutations affecting the myeloid lineage.
Recent experimental evidence was thoroughly reviewed, with findings which elicit a complex role for eosinophils, in a tight balance between host defense and tissue damage. Eventually, emerging evidence about eosinophils in COVID-19 infection was also discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CCL17:
-
C-C motif chemokine ligand 17
- CCL22:
-
C-C motif chemokine ligand 22
- CCR3:
-
C-C chemokine receptor type 3
- FGF-2:
-
fibroblast growth factors 2
- GM-CSF:
-
granulocyte-macrophage colony-stimulating factor
- IFNγ:
-
interferon gamma
- IL-10:
-
interleukin 10
- IL-12:
-
interleukin 12
- IL-17:
-
interleukin 17
- IL-23:
-
interleukin 23
- IL-25:
-
interleukin 25
- IL-3:
-
interleukin 3
- IL-4:
-
interleukin 4
- IL-33:
-
interleukin 33
- IL-5:
-
interleukin 5
- IL-6:
-
interleukin 6
- PTX3:
-
pentraxin 3
- TGF-β:
-
transforming growth factor β
- TNF-α:
-
tumor necrosis factor alpha α
- TSLP:
-
thymic stromal lymphopoietin
- Th1:
-
T helper 1
- Th2:
-
T helper 2
- NK cell:
-
natural killer cell
- FcεRI:
-
high-affinity IgE receptor
- FcεRIα:
-
high-affinity IgE receptor alpha chain
- MBP:
-
major basic protein
- ECP:
-
eosinophilic cationic protein
- EPO:
-
eosinophil peroxidase
- ROS:
-
reactive oxygen species
- EDN:
-
eosinophil-derived neurotoxin
- PMD:
-
piecemeal degranulation
- EoSVs:
-
eosinophil sombrero vesicles
- EET:
-
eosinophil extracellular traps
- ILC2:
-
innate lymphoid cell type 2
- PRRs:
-
pattern recognition receptors
- PAMPs:
-
pathogen-associated molecular patterns
- LPS:
-
lipopolysaccharide
- DAMPs:
-
damage-associated molecular patterns
- TLRs:
-
toll-like receptors
- APCs:
-
antigen-presenting cells
- MHC-II:
-
major histocompatibility complex class II
- DCs:
-
dendritic cells
- GI tract:
-
gastrointestinal tract
- RVS:
-
respiratory syncytial virus
- HIV:
-
human immunodeficiency virus
- AIDS:
-
acquired immunodeficiency syndrome
- SARS-CoV-2:
-
SARS-2 coronavirus
- COVID-19:
-
coronavirus disease 19
- BAL:
-
bronchoalveolar lavage
- ADCC:
-
antibody-dependent cellular cytotoxicity
- AD:
-
atopic dermatitis
- AR:
-
allergic rhinitis
- HES:
-
hypereosinophilic syndrome
- AEP:
-
acute eosinophilic pneumonia
- CEP:
-
chronic eosinophilic pneumonia
- EGPA:
-
eosinophilic granulomatosis with polyangiitis
- ANCA:
-
antineutrophil cytoplasmic antibodies
- TME:
-
tumor microenvironment
- TATE:
-
tumor-associated tissue eosinophilia
- CTLs:
-
cytotoxic T-lymphocytes
- OSCC:
-
oral squamous cell carcinoma
- DFS:
-
disease-free survival
- MN-eos:
-
eosinophilia-associated myeloid neoplasms
- FGFR1:
-
fibroblast growth factor receptor 1
- PDGFRα:
-
platelet-derived growth factor receptor a
- PDGFRβ:
-
platelet-derived growth factor receptor b
- MPN:
-
myeloproliferative neoplasms
- CEL-NOS:
-
chronic eosinophilic leukemia-not otherwise specified
- CML:
-
chronic myeloid leukemia
- Eos-CML:
-
hypereosinophilic variant
- HL:
-
Hodgkin’s lymphoma
References
Abidi K et al (2008) Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care 12
Alkhabuli JO, High AS (2006) Significance of eosinophil counting in tumor associated tissue eosinophilia (TATE). Oral Oncol 42:849–850
ARCHER GT, HIRSCH JG (1963) Motion picture studies on degranulation of horse eosinophils during phagocytosis. J Exp Med 118:287–294
Aupperlee MD et al (2014) Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland. Endocrinology 155:2301–2313
Bachert C, Patou J, Van Cauwenberge P (2006) The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol 6:29–36
Barker E, Mackewicz CE, Levy JA (1995) Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci U S A 92:11135–11139
Bass DA (1975) Behavior of eosinophil leukocytes in acute inflammation. II Eosinophil dynamics during acute inflammation. J Clin Invest 56:870–879
Bertheloot D, Latz E (2017) HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol
Birring SS et al (2005) Sputum eosinophilia in idiopathic pulmonary fibrosis. Inflamm Res 54:51–56
Biswas SK, Mantovani A (2010) Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat Immunol
Brinkmann V et al (2004) Neutrophil extracellular traps kill bacteria. Science 303(80):1532–1535
Brunetta E et al (2020) Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat Immunol 22
Butterworth AE (1985) Cell-mediated damage to helminths. Adv Parasitol 23:143–235
Bystrom J, Amin K, Bishop-Bailey D (2011) Analysing the eosinophil cationic protein – a clue to the function of the eosinophil granulocyte. Respir Res 12
Cambier J, Morrison D (1991) Modeling of T cell contact-dependent B cell activation. IL-4 and antigen receptor ligation primes quiescent B cells to mobilize calcium in response to Ia cross-linking. J Immunol:2075–2082
Capron Loiseau M et al (2016) Human eosinophils exert TNF- human eosinophils exert TNF-a and granzyme A-mediated tumoricidal activity toward colon carcinoma cells. J Immunol
Carretero R et al (2015) Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8 + T cells. Nat Immunol
Chou A, Serpa JA (2015) Eosinophilia in patients infected with human immunodeficiency virus. Curr HIV/AIDS Rep 12:313–316
Chu DK et al (2014) Indigenous enteric eosinophils control DCs to initiate a primary Th2 immune response in vivo. J Exp Med 211:1657–1672
Cline MJ, Lehrer RI (1968) Phagocytosis by human monocytes. Blood 32:423–435
Conroy DM, Williams TJ (2001) Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2:150–156
Costain DJ, Guha AK, Liwski RS, Lee TDG (2001) Murine hypodense eosinophils induce tumour cell apoptosis by a granzyme B-dependent mechanism. Cancer Immunol Immunother
Costello RW et al (1999) Antigen-induced hyperreactivity to histamine: Role of the vagus nerves and eosinophils. Am J Physiol 276
Curtis C, Ogbogu P (2016) Hypereosinophilic syndrome. Clin Rev Allergy Immunol 50:240–251
Cuschieri A et al (2002) Influence of pathological tumour variables on long-term survival in resectable gastric cancer. Br J Cancer
Cyriac S, Sagar TG, Rajendranath R, Rathnam K (2008) Hypereosinophilia in hodgkin lymphoma. Indian J Hematol Blood Transfus
Davido B et al (2017) Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy. Int J Infect Dis 61:62–66
Davoine F, Lacy P (2014) Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol 5
Decot V et al (2005) Heterogeneity of expression of IgA receptors by human, mouse, and rat eosinophils. J Immunol 174:628–635
Del Pozo V et al (1992) Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. Eur J Immunol 22:1919–1925
Domachowske JB, Dyer KD, Adams AG, Leto TL, Rosenberg HF (1998) Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res 26
Du Y et al (2020) Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med 201:1372–1379
Durack DT, Sumi SM, Klebanoff SJ (1979) Neurotoxicity of human eosinophils. Proc Natl Acad Sci U S A 76:1443–1447
Dworski R, Simon HU, Hoskins A, Yousefi S (2011) Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J Allergy Clin Immunol 127:1260–1266
Elbon CL, Jacoby DB, Fryer AD (1995) Pretreatment with an antibody to interleukin-5 prevents loss of pulmonary M2 muscarinic receptor function in antigen-challenged Guinea pigs. Am J Respir Cell Mol Biol 12:320–328
Elishmereni M et al (2011) Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy Eur J Allergy Clin Immunol 66:376–385
Esposito I et al (2004) Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol
Falchi L, Verstovsek S (2015) Eosinophilia in hematologic disorders. Immunol Allergy Clin N Am 35:439–452
Fischer E, Capron M, Prin L, Kusnierz JP, Kazatchkine MD (1986) Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3. Cell Immunol 97:297–306
Fryer AD et al (2006) Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. J Clin Invest 116:228–236
Fulkerson PC, Rothenberg ME (2013) Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov 12:117–129
Fulkerson PC, Rothenberg ME (2018) Eosinophil development, disease involvement, and therapeutic suppression. Adv Immunol 138:1–34
Furue M et al (2017) Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergol Int 66:398–403
Furuta GT, Katzka DA (2015) Eosinophilic esophagitis. N Engl J Med 373:1640–1648
Gajewski TF, Schreiber H, Fu YX (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol
Garro AP, Chiapello LS, Baronetti JL, Masih DT (2011) Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4+ and CD8+ T cells with a T-helper 1 profile. Immunology 132:174–187
Gatault S, Legrand F, Delbeke M, Loiseau S, Capron M (2012) Involvement of eosinophils in the anti-tumor response. Cancer Immunol Immunother 61:1527–1534
Gleich GJ (2000) Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105:651–663
Gleich GJ, Adolphson CR (1986) The eosinophilic leukocyte: structure and function. Adv Immunol 39:177–253
Gleich GJ, Adolphson C (1993) Bronchial hyperreactivivity and eosinophil granule proteins. Agents Actions 43:223–230
Glimelius I et al (2011) Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines. Exp Hematol
Goh YPS et al (2013) Eosinophils secrete IL-4 to facilitate liver regeneration. Proc Natl Acad Sci U S A 110:9914–9919
Gounni AS et al (1994) High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367:183–186
Gouon-Evans V, Rothenberg ME, Pollard JW (2000) Postnatal mammary gland development requires macrophages and eosinophils. Development 127:2269–2282
Gouon-Evans V, Lin EY, Pollard JW (2002) Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res 4:155–164
Grangette C et al (1989) IgE receptor on human eosinophils (FcERII). Comparison with B cell CD23 and association with an adhesion molecule. J Immunol 143
Greco A et al (2015) Churg-Strauss syndrome. Autoimmun Rev 14:341–348
Guerra ES et al (2017) Central role of IL-23 and IL-17 producing eosinophils as immunomodulatory effector cells in acute pulmonary aspergillosis and allergic asthma. PLoS Pathog 13
Hallam C, Pritchard DI, Trigg S, Eady RP (1982) Rat eosinophil-mediated antibody-dependent cellular cytotoxicity: investigations of the mechanisms of target cell lysis and inhibition by glucocorticoids. Clin Exp Immunol 48:641–648
Hartnell A, Kay AB, Wardlaw AJ (1992) IFN-gamma induces expression of Fc gamma RIII (CD16) on human eosinophils. J Immunol 148
Hasford J et al (1998) A new prognostic score for survival of patients with chronic myeloid leukemia treated with Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Group. JNCI J Natl Cancer Inst
Hassani M et al (2020) Differentiation and activation of eosinophils in the human bone marrow during experimental human endotoxemia. J Leukoc Biol
Hogan SP et al (2001) A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol 2:353–360
Hogan SP et al (2008a) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38:709–750
Hogan SP et al (2008b) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38:709–750
Hotez PJ, Bottazzi ME, Corry DB (2020) The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement. Microb Infect 22
Hu G et al (2020) Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: a meta-analysis. BMC Cancer 20:1–9
Huang L, Appleton JA (2016) Eosinophils in helminth infection: defenders and dupes. Trends Parasitol 32:798–807
Huang L et al (2014) Eosinophil-derived IL-10 supports chronic nematode infection. J Immunol 193:4178–4187
Jacobsen EA et al (2008) Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med 205:699–710
Jesenak M, Banovcin P, Diamant Z (2020) COVID-19, chronic inflammatory respiratory diseases and eosinophils – observations from reported clinical case series. Allergy
Jin JJ, Butterfield JH, Weiler CR (2015) Hematologic malignancies identified in patients with hypereosinophilia and hypereosinophilic syndromes. J Allergy Clin Immunol Pract 3:920–925
Johnson RC, George TI (2013) The differential diagnosis of eosinophilia in neoplastic hematopathology. Surg Pathol Clin 6:767–794
Jordan MB, Mills DM, Kappler J, Marrack P, Cambier JC (2004) Promotion of B cell immune responses via an alum-induced myeloid cell population. Science 304(80):1808–1810
Kephart GM et al (2010) Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol 105:298–307
Khandpur R et al (2013) NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 5:178ra40-178ra40
Kiziltaş Ş, Ramadan SS, Topuzoǧlu A, Küllü S (2008) Does the severity of tissue eosinophilia of colonic neoplasms reflect their malignancy potential? Turkish J Gastroenterol
Klion AD, Nutman TB (2004) The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 113:30–37
Kojima K, Sasaki T (1995) Veno-occlusive disease in Hypereosinophilic syndrome. Intern Med 34:1194–1197
Kopf M et al (1996) IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15–24
Kurose N et al (2019) Adenosquamous carcinoma of the uterine cervix displaying tumor-associated tissue eosinophilia. SAGE Open Med Case Rep 7:2050313X1982823
Legrand F et al (2010) Human eosinophils exert TNF-α and granzyme A-mediated tumoricidal activity toward colon carcinoma cells. J Immunol 185:7443–7451
Leigh R et al (2000) Eosinophil cationic protein relates to sputum neutrophil counts in healthy subjects. J Allergy Clin Immunol 106:593–594
Liao M et al (2020) Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med 26:842–844
Lorena SCM, Oliveira DT, Dorta RG, Landman G, Kowalski LP (2003) Eotaxin expression in oral squamous cell carcinomas with and without tumour associated tissue eosinophilia. Oral Dis
Louie JK et al (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA – J Am Med Assoc 302:1896–1902
Mantis NJ, Rol N, Corthésy B (2011) Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 4:603–611
Matsushima T et al (2003) Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia. Blood
Mawhorter SD, Pearlman E, Kazura JW, Henry Boom W (1993) Class II major histocompatibility complex molecule expression on murine eosinophils activated In Vivo by Brugia Malayi. Infect Immun 61
McBrien CN, Menzies-Gow A (2017) The biology of eosinophils and their role in asthma. Front Med 4:93
McBrien CN, Menzies-Gow A (2018) Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis. Drugs Today 54:93
McKinney EF, Willcocks LC, Broecker V, Smith KGC (2014) The immunopathology of ANCA-associated vasculitis. Semin Immunopathol 36:461–478
Melo RCN, Weller PF (2010) Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses. Histol Histopathol 25:1341–1354
Melo RCN, Perez SAC, Spencer LA, Dvorak AM, Weller PF (2005a) Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. Traffic 6:866–879
Melo RCN et al (2005b) Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. Traffic 6:1047–1057
Minshall EM et al (1997) Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 17:326–333
Moore WC et al (2010) Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med 181:315–323
Mukherjee M, Lacy P, Ueki S (2018) Eosinophil extracellular traps and inflammatory pathologies-untangling the web! Front Immunol 9
Murdoch C, Muthana M, Coffelt SB, Lewis CE (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer
Noel P (2012) Eosinophilic myeloid disorders. Semin Hematol 49:120–127
Odemuyiwa SO et al (2004) Cutting edge: human eosinophils regulate T cell subset selection through Indoleamine 2,3-dioxygenase. J Immunol 173:5909–5913
Ohno I et al (1996) Transforming growth factor β1 (TGFβ1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol 15:404–409
Ortega HG et al (2014) Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 371:1198–1207
Ownby HE, Roi LD, Isenberg RR, Brennan MJ (1983) Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer
Padigel UM et al (2007) Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis 196:1844–1851
Pégorier S, Wagner LA, Gleich GJ, Pretolani M (2006) Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J Immunol 177:4861–4869
Pereira MC, Oliveira DT, Kowalski LP (2011) The role of eosinophils and eosinophil cationic protein in oral cancer: a review. Arch Oral Biol 56:353–358
Persson T et al (2001) Bactericidal activity of human eosinophilic granulocytes against Escherichia coli. Infect Immun 69:3591–3596
Phipps S et al (2007) Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 110:1578–1586
Piehler D et al (2011) Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary cryptococcosis. Am J Pathol 179:733–744
Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by Macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72:2855–2864
Ponikau JU et al (2005) Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis. J Allergy Clin Immunol 116:362–369
Prizment AE, Anderson KE, Visvanathan K, Folsom AR (2011) Inverse association of eosinophil count with colorectal cancer incidence: atherosclerosis risk in communities study. Cancer Epidemiol Biomark Prev
Provost V et al (2013) CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2. J Leukoc Biol 94:213–222
Puxeddu I et al (2010) Osteopontin is expressed and functional in human eosinophils. Allergy Eur J Allergy Clin Immunol
Rached AA, Hajj WE (2016) Eosinophilic gastroenteritis: approach to diagnosis and management. World J Gastrointest Pharmacol Ther 7:513
Rakesh N, Devi Y, Majumdar K, Reddy SS, Agarwal K (2015) Tumour associated tissue eosinophilia as a predictor of locoregional recurrence in oral squamous cell carcinoma. J Clin Exp Dent
Ramirez GA et al (2018) Eosinophils from physiology to disease: a comprehensive review. Biomed Res Int 2018
Ravin KA, Loy M (2015) The eosinophil in infection. Clin Rev Allergy Immunol 50:214–227
Reichman H et al (2019) Activated eosinophils exert antitumorigenic activities in colorectal cancer. Cancer Immunol Res 7:388–400
Reiter A, Gotlib J (2017) Myeloid neoplasms with eosinophilia. Ann Intern Med 129:704–714
Rosenberg HF, Dyer KD, Foster PS (2013) Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 13:9–22
Rothenberg ME, Hogan SP (2006) The Eosinophil. Annu Rev Immunol 24:147–174
Roufosse F, Cogan E, Goldman M (2007) Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin N Am
Roufosse F, Garaud S, De Leval L (2012) Lymphoproliferative disorders associated with hypereosinophilia. Semin Hematol
Sablé-Fourtassou R et al (2005) Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 143:632–638
Sakkal S, Miller S, Apostolopoulos V, Nurgali K (2016) Eosinophils in cancer: favourable or unfavourable? Curr Med Chem
Samarasinghe AE et al (2017) Eosinophils promote antiviral immunity in mice infected with influenza a virus. J Immunol 198:3214–3226
Samoszuk M (1997) Eosinophils and human cancer. Histol Histopathol
Saraiva AL, Carneiro F (2018) New insights into the role of tissue eosinophils in the progression of colorectal cancer: a literature review. Acta Med Portuguesa 31:329–337
Schrezenmeier H, Thome SD, Tewald F, Fleischer B, Raghavachar A (1993) Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Exp Hematol
Schroeder JW et al (2019) Anti-neutrophil cytoplasmic antibodies positivity and anti-leukotrienes in eosinophilic granulomatosis with polyangiitis: a retrospective monocentric study on 134 Italian patients. Int Arch Allergy Immunol 180:64–71
Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G (2004) The role of human mast cell-derived cytokines in eosinophil biology. J Interferon Cytokine Res 24:271–281
Shamri R, Xenakis JJ, Spencer LA (2011) Eosinophils in innate immunity: an evolving story. Cell Tissue Res 343:57–83
Shomali W, Gotlib J (2019) World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. Am J Hematol 94:1149–1167
Silveira JS et al (2019) Respiratory syncytial virus increases eosinophil extracellular traps in a murine model of asthma. Asia Pac Allergy 9
Simon HU et al (1996) Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med
Simon HU, Plötz SG, Dummer R, Blaser K (1999) Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med
Simon HU et al (2010) Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 126:45–49
Simon D et al (2011) Eosinophil extracellular DNA traps in skin diseases. J Allergy Clin Immunol 127:194–199
Siracusa MC et al (2011) TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 477:229–233
Smyth CM et al (2013) Activated eosinophils in association with enteric nerves in inflammatory bowel disease. PLoS One 8:e64216
Spencer LA et al (2006) Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc Natl Acad Sci U S A 103:3333–3338
Spencer LA, Bonjour K, Melo RCN, Weller PF (2014) Eosinophil secretion of granule-derived cytokines. Front Immunol 5
Stenfeldt AL, Wennerås C (2004) Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology 112:605–614
Straumann A et al (2010) Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 59:21–30
Su Y-C et al (2015) Dual Proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease. J Virol 89:1564–1578
Subeikshanan V et al (2016) A prospective comparative clinical study of peripheral blood counts and indices in patients with primary brain tumors. J Postgrad Med
Suchin KR et al (2001) Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12. J Am Acad Dermatol
Suzuki Y, Suda T (2019) Eosinophilic pneumonia: a review of the previous literature, causes, diagnosis, and management. Allergol Int 68:413–419
Svensson L, Wennerås C (2005) Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups. Microbes Infect 7:720–728
Taylor RJ, Schols D, Wooley DP (2004) Restricted entry of R5 HIV type 1 strains into eosinophilic cells. AIDS Res Hum Retrovir 20:1244–1253
Terai M et al (2011) Early induction of interleukin-5 and peripheral eosinophilia in acute pneumonia in Japanese children infected by pandemic 2009 influenza a in the Tokyo area. Microbiol Immunol 55:341–346
Teruya-Feldstein J et al (1999) Differential chemokine expression in tissues involved by Hodgkin’s disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood
Thielen C et al (2008) TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas. Leuk Res
Thorne KJI, Glauert AM, Svvennsen RJ, Franks D (1979) Phaġocytosis and killinġ of Trypanosoma dionisii by human neutrophils, eosinophils and monocytes. Parasitology 79:367–379
Throsby M, Herbelin A, Pléau J-M, Dardenne M (2000) CD11c + eosinophils in the murine thymus: developmental regulation and recruitment upon MHC class I-restricted thymocyte deletion. J Immunol 165:1965–1975
Torrent M, Navarro S, Moussaoui M, Nogués MV, Boix E (2008) Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans. Biochemistry 47:3544–3555
Vaillant L, La Ruche G, Tarantola A, Barboza P (2009) Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 14
Valent P, Sperr WR, Schwartz LB, Horny HP (2004) Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. J Allergy Clin Immunol
van Kerkhove MD et al (2011) Risk factors for severe outcomes following 2009 influenza a (H1N1) infection: a global pooled analysis. PLoS Med 8
Varricchi G et al (2018) Eosinophils: the unsung heroes in cancer? OncoImmunology
Von Köckritz-Blickwede M, Nizet V (2009) Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. J Mol Med 87:775–783
Vrtis, W. M. et al. Virus-specific T cells eosinophils bind rhinovirus and activate. (2020)
Wang YH et al (2007) IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 204:1837–1847
Wardlaw AL (1999) Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol 104:917–926
Wechsler ME et al (2017) Mepolizumab or placebo for eosinophilic granulomatosis with Polyangiitis. N Engl J Med 376:1921–1932
Weller PF, Goetzl EJ (1980) The human eosinophil: roles in host defense and tissue injury. Am J Pathol 100:791–820
Weller PF, Spencer LA (2017) Functions of tissue-resident eosinophils. Nat Rev Immunol 17:746–760
Wen T, Rothenberg ME (2016) The regulatory function of eosinophils. In: Myeloid cells in health and disease, vol 4. American Society of Microbiology, pp 257–269
Werfel T et al (2016) Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol 138:336–349
White JR et al (1997) Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol 62:667–675
Williams KW et al (2016) Hypereosinophilia in children and adults: a retrospective comparison. J Allergy Clin Immunol. Pract 4:941–947.e1
Wimazal F et al (2010) Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes. Cancer
Wong CK, Cheung PFY, Ip WK, Lam CWK (2007) Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol 37:85–96
Wong CK, Ng SSM, Lun SWM, Cao J, Lam CWK (2009) Signalling mechanisms regulating the activation of human eosinophils by mast-cell-derived chymase: implications for mast cell-eosinophil interaction in allergic inflammation. Immunology 126:579–587
Wong CK, Hu S, Cheung PFY, Lam CWK (2010) Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol 43:305–315
Wong TW, Doyle AD, Lee JJ, Jelinek DF (2014) Eosinophils regulate peripheral B cell numbers in both mice and humans. J Immunol 192:3548–3558
Yancey SW et al (2017) Biomarkers for severe eosinophilic asthma. J Allergy Clin Immunol 140:1509–1518
Yang D et al (2003) Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood 102:3396–3403
Yang D et al (2004) Human ribonuclease a superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. J Immunol 173:6134–6142
Yellapurkar S et al (2016) Tumour-associated tissue eosinophilia in oral squamous cell carcinoma- a boon or a bane? J Clin Diagnos Res
Yousefi S et al (2008) Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 14:949–953
Yousefi S et al (2018) Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation. J Leukoc Biol 104:205–214
Zeck-Kapp G, Kroegel C, Riede UN, Kapp A (1995) Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations. Allergy 50:34–47
Zhang MM, Li YQ (2017) Eosinophilic gastroenteritis: a state-of-the-art review. J Gastroenterol Hepatol (Australia) 32:64–72
Zhang J et al (2012) Pentraxin 3 (PTX3) expression in allergic asthmatic airways: role in airway smooth muscle migration and chemokine production. PLoS One 7
Zhang Y et al (2014) Clinical impact of tumor-infiltrating inflammatory cells in primary small cell esophageal carcinoma. Int J Mol Sci
Zhang JJ et al (2020) Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy Eur J Allergy Clin Immunol
Ziegler SF et al (2013) The biology of thymic stromal lymphopoietin (TSLP). In: Advances in pharmacology, vol 66. Academic, pp 129–155
Acknowledgments
Figures 1 and 3, created with BioRender.com
Figure 2 created with MindGraph.
Conflict of Interest
All authors declare they have no conflict of interest and they have not received any financial support for this work.
Ethical Approval
The authors declare that this article does not contain any studies with human participants or animals.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Folci, M., Ramponi, G., Arcari, I., Zumbo, A., Brunetta, E. (2021). Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 14. Advances in Experimental Medicine and Biology(), vol 1347. Springer, Cham. https://doi.org/10.1007/5584_2021_640
Download citation
DOI: https://doi.org/10.1007/5584_2021_640
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-80491-6
Online ISBN: 978-3-030-80492-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)